Publications by authors named "Nayan Acharya"

Claim this Profile
I
Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies.
Christopher E M Griffiths, Maurizio Fava, Andrew H Miller, James Russell, Susan G Ball, Nayan Acharya

Psychother Psychosom· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data.
Bruce Strober, Craig Leonardi, Kim A Papp, Ulrich Mrowietz, Mamitaro Ohtsuki, Nayan Acharya

J Am Acad Dermatol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials.
Kristian Reich, Craig Leonardi, Richard G Langley, Richard B Warren, Hervé Bachelez, Nayan Acharya

J Am Acad Dermatol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Psoriatic Disease Payer Advisory Panel.
Jacqueline E Greb, Joseph Merola, Amit Garg, John Latella, Leah Howard, Nayan Acharya

J Drugs Dermatol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications.
Andrew T McAfee, Joan Landon, Meghan Jones, Mark E Bangs, Nayan Acharya

Pharmacoepidemiol Drug Saf· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine.
Ludmila A Kryzhanovskaya, Wen Xu, Brian A Millen, Nayan Acharya, Kai Yu Jen

J Child Adolesc Psychopharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics.
Olawale Osuntokun, Brian Millen, Wen I Xu, Ludmilla A Kryzhanovskaya, Carol Robertson-Plouch, Nayan Acharya

J Psychopharmacol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.
Jerry A Hall, Fujun Wang, Tina M Myers Oakes, Barbara G Utterback, Antonio Crucitti, Nayan Acharya

Expert Opin Drug Saf· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Answers to the most common questions about the hepatic safety profile of duloxetine.
Madelaine M Wohlreich, Nayan Acharya, Indiana Strombom, Louis Kuritzky, Michael Robinson

Postgrad Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events.
Joachim Wernicke, Nayan Acharya, Indiana Strombom, James L Gahimer, Deborah N D'Souza

Curr Drug Saf· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.
Indiana Strombom, Joachim F Wernicke, John Seeger, Deborah N D'Souza, Nayan Acharya

Curr Drug Saf· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD.
John Polzer, Mark E Bangs, Shuyu Zhang, Mary Anne Dellva, Sitra Tauscher-Wisniewski, Nayan Acharya

Biol Psychiatry· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and effectiveness of newer antiepileptics: a comparative postmarketing cohort study.
Nayan V Acharya, Ruth M Pickering, Lynda W Wilton, Saad A W Shakir

J Clin Pharmacol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis